Journal article Published 2023

Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients

Alona Řehulková, Josef Chudáček, Andrea Prokopová, Monika Vidlařová, Jana Stránská, Jiří Drábek, Jana Potočková, Radek Trojanec, Jana Vrbková, Jozef Škarda, Tomáš Bohanes, Marek Szkorupa, B. Tolmaci, Jiří Klein, Josef Srovnal,

Show all 16 authors

Marián Hajdúch

Translational Lung Cancer Research 12(5), 1034-1050 (2023)

View on PubMed Cite

2023 Year
37323172 PMID

Cite this publication

ŘEHULKOVÁ, A., J. CHUDÁČEK, A. PROKOPOVÁ, M. VIDLAŘOVÁ, J. STRÁNSKÁ, J. DRÁBEK, J. POTOČKOVÁ, R. TROJANEC, J. VRBKOVÁ, J. ŠKARDA, T. BOHANES, M. SZKORUPA, B. TOLMACI, J. KLEIN, J. SROVNAL, M. HAJDÚCH: Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients. Translational Lung Cancer Research. 2023, 12(5), 1034-1050, ISSN: 2226-4477 , PMID: 37323172.

Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients

Cite this publication

Details

Authors from EATRIS